Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1254 Official Publication of Indian Association of Medical Microbiologists 
 ~   Next article
 ~   Previous article
 ~   Table of Contents

 ~   Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~   Citation Manager
 ~   Access Statistics
 ~   Reader Comments
 ~   Email Alert *
 ~   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded8    
    Comments [Add]    

Recommend this journal


Year : 1988  |  Volume : 6  |  Issue : 4  |  Page : 269-273

Susceptibility Of Coliforms To Augmentin

Correspondence Address:
D Raghunath

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Susceptibility of 111 clinical isolates of coliforms was studied against Augmentin a formulation of amoxycillin and beta lactamase inhibitor clavulanic acid. These coliforms included Escherichia coli (74), Klebsiella spp (28) and Proteus spp (9). Minimum inhibitory concentrations of amoxycillin and Augmentin were determined against these coliforms by agar dilution technique. All the E. coli and Proteus spp were resistant to 16 mg/1 of amoxycillin whereas all Klebsiella spp were resistant to 32 mg/1. MIC of > 256 mg/1 of amoxycillin was seen in 93.2% of E. coli, 75% of Klebsiella spp and 89% of Proteus spp. MIC values against Augmentin were encouraging. 97.3% of E. coli, 96.4% of Klebsiella spp and 88.9% of Proteus spp were susceptible to 16 mg/1 of Augmentin. The value of Augmentin in treating ampicillin resistant organisms is highlighted.

[PDF Not available]*

Print this article     Email this article

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04